Li et al. (2020) identified an association between PYGB expression and smoking, linking it to LUSC progression. In prostate cancer, PYGB activation via NF-κB/Nrf2 signaling contributes to enhanced proliferation, migration, and aggressiveness (Wang et al., 2018). Here, PYGB is linked to prostate carcinoma.